We’re looking for women ages 35-42 to participate in The PROGRESS Study

The PROGRESS Study is an investigational study to determine if Progesterone-IBSA administered as an injection under the skin (subcutaneous) is safe and effective in supporting the implantation and early pregnancy following a frozen embryo transfer (FET).

About the Sponsor:

IBSA Group, the study Sponsor, is a multinational pharmaceutical company headquartered in Switzerland, operating in 90 countries around the globe (including US). IBSA is one of the major players worldwide in the field of Reproductive Medicine.

About the Study:

The hormone progesterone plays a vital role in earl pregnancy. Our researchers are investigating an alternative way to administer progesterone with the aim to discover if subcutaneous (under-the-skin) injections are as safe and effective as the current approved medication Crinone®.

Crinone® is a progesterone gel that is administered vaginally and has been approved by the United States Food and Drug Administration, or FDA. The use of Progesterone-IBSA in this study is investigational. An investigational use is one that is not approved by FDA. However, Progesterone-IBSA is already approved and marketed in more than 30 countries worldwide.

The PROGRESS Trial is registered with, a website run by the National Institutes of Health (NIH) that provides information about clinical trials, and can be found at Clinical Trials NC NCT04549116.

You may be eligible for the study if you fall into one of the following two categories:

You are undergoing or plan to undergo an ovarian stimulation treatment to produce multiple octes (eggs) and are interested in preimplantation genetic testing for aneuploidy (PGT-A) of the embrvos.

You have already undergone ovarian stimulation in the past and have a frozen euploid embryo and you qualify for a frozen embryo transfer (FET).

And meet the following criteria:

  • Age 35-42
  • Are planning a single frozen embryo transfer
  • Have regular menstrual cycles (24-38 days)
  • Do not have history of recurrent pregnancy loss
  • (2 or more consecutive losses)
  • Have a BMI of <38 kg/m2


[email protected]

OR CALL 801-785-5100 EXT. 7036